Antihypertensive Treatment and Cancer: Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Observational Studies
The Journal of Tehran University Heart Center · 06.06.2026
DOI: 10.18502/jthc.v21i2.21694 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Tehran University Heart Center, online erschienen am 06.06.2026. Verfasst von Aghil Rostami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Non-Communicable Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Data on the link between use of antihypertensive medications and the risk of developing or dying from cancer have uncertain credibility and certainty.
Objectives
We sought to evaluate the credibility of evidence from observational studies and the certainty of evidence from randomized controlled trials (RCTs) on the association between antihypertensive medication use and cancer risk, mortality, or survival outcomes.
Methods
Comprehensive searches were performed in PubMed, Embase, Scopus, and the Cochrane Database of Systematic Reviews from their creation through July 2024. The study included systematic reviews and meta-analyses of epidemiological research investigating the relationships between antihypertensive therapies and cancer risk, mortality, or survival outcomes. The credibility of evidence from observational studies was categorized as convincing, highly suggestive, suggestive, weak, or nonsignificant. Through the GRADE framework, the certainty of evidence from RCTs was categorized as high, moderate, low, or very low.
Results
A total of 109 meta-analyses were identified, with 90 originating from observational studies and 23 from RCTs. The observational studies provided highly suggestive evidence that calcium channel blockers (CCBs) and diuretics were associated with an increased cancer risk (equivalent odds ratio [eOR], 1.07; 95% CI, 1.04 to 1.10; and eOR, 1.15; 95% CI, 1.10 to 1.20, respectively). Evidence suggests that β-blockers are associated with an increase in cancer-specific survival (eOR, 0.78; 95% CI, 0.69 to 0.89). No association satisfied the standards for convincing evidence. Pooled analyses of RCTs determined that CCB use was associated with an increased cancer risk (eOR, 1.06; 95% CI, 1.01 to 1.12; moderate certainty).
Conclusions
No strong or consistent evidence was found to support a causal relationship between antihypertensive medications and cancer outcomes. The observed associations were of very small magnitude, suggesting limited clinical relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Non-Communicable Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
- Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
- Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Surgery, Surgery Research Center, Rasool E Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Aghil Rostami, Kazem Rahimi, Haleh Ashraf, Hesam Mosavari, Noushin Fahimfar
Zitieren
APA
Rostami, A., Rahimi, K., Ashraf, H., Mosavari, H., & Fahimfar, N. (2026). Antihypertensive Treatment and Cancer: Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Observational Studies. The Journal of Tehran University Heart Center. https://doi.org/10.18502/jthc.v21i2.21694
Vancouver
Rostami A, Rahimi K, Ashraf H, Mosavari H, Fahimfar N. Antihypertensive Treatment and Cancer: Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Observational Studies. The Journal of Tehran University Heart Center. 2026. doi:10.18502/jthc.v21i2.21694
BibTeX
@article{Rostami2026,
author = {Rostami, Aghil and Rahimi, Kazem and Ashraf, Haleh and Mosavari, Hesam and Fahimfar, Noushin},
title = {Antihypertensive Treatment and Cancer: Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Observational Studies},
journal = {The Journal of Tehran University Heart Center},
year = {2026},
doi = {10.18502/jthc.v21i2.21694}
}
EUVIMED